{"id":209268,"name":"REVIVE THERAPEUTICS INC.","slug":"revive-therapeutics-inc","state":null,"country":"Canada","description":"pharmaceutical and therapeutics manufacturer","totalSpending":115000,"filings":11,"yearlySpending":[{"year":2021,"income":90000},{"year":2022,"income":25000},{"year":2023,"income":0}],"issues":[{"code":"HCR","display":"Health Issues"}],"firms":["GRASSROOTS POLITICAL CONSULTING LLC"],"lobbyists":["DANIEL FARACI"],"govEntities":["Natl Institutes of Health (NIH)","SENATE","Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES"],"sampleDescriptions":["Advocating for acceleration and approval of bucillamine as a COVID-19 critical therapeutic solution. In addition, advocating for TBI, PTSD applications of other medicines in development.","Advocating for assistance w/Phase 3 trial for Bucillamine","Advocating for assistance w/Phase 3 trial for Bucillamine, educating Members of Congress, BARDA/HHS and NIH regarding Bucillamine as a repurposed drug for COVID19.","Advocating for assistance w/Phase 3 trial for Bucillamine, educating Members of Congress, BARDA/HHS and NIH regarding Bucillamine as a repurposed drug for COVID19.","Advocating for assistance w/Phase 3 trial for Bucillamine, educating Members of Congress, BARDA/HHS and NIH regarding Bucillamine as a repurposed drug for COVID19."]}